US OptionsDetailed Quotes
ABT240913C107000
- 9.51
- -0.72-7.04%
15min DelayClose Sep 13 16:00 ET
9.51High9.51Low
9.51Open10.23Pre Close2 Volume4 Open Interest107.00Strike Price1.90KTurnover2226.22%IV0.09%PremiumSep 13, 2024Expiry Date9.40Intrinsic Value100Multiplier-1DDays to Expiry0.11Extrinsic Value100Contract SizeAmericanOptions Type0.9785Delta0.0104Gamma12.79Leverage Ratio-88.3072Theta0.0000Rho12.52Eff Leverage0.0001Vega
Abbott Laboratories Stock Discussion
Sign in to post a comment
Morning Movers
Gapping up
$Royal Philips (PHG.US)$ experienced a significant boost of 10.6% after the company reported robust second-quarter earnings, attributing much of their success to cost-saving measures, including workforce reductions, and a substantial insurance payout related to liability claims.
$Tesla (TSLA.US)$ 's shares advanced by 1.9% following an endorsement by Morgan Stanley analyst Adam Jonas, naming it the top ...
Gapping up
$Royal Philips (PHG.US)$ experienced a significant boost of 10.6% after the company reported robust second-quarter earnings, attributing much of their success to cost-saving measures, including workforce reductions, and a substantial insurance payout related to liability claims.
$Tesla (TSLA.US)$ 's shares advanced by 1.9% following an endorsement by Morgan Stanley analyst Adam Jonas, naming it the top ...
33
8
The earnings season is picking up speed, and this mid-July, we're about to get updates from some of the biggest names across various industries. Expect to hear from large banks, healthcare companies, airlines, and some of the tech and telecom giants that we all know.
The season started off last Friday with $JPMorgan (JPM.US)$ , $Wells Fargo & Co (WFC.US)$ , and $Wells Fargo & Co (WFC.US)$ sharing their numbers. They all did bett...
The season started off last Friday with $JPMorgan (JPM.US)$ , $Wells Fargo & Co (WFC.US)$ , and $Wells Fargo & Co (WFC.US)$ sharing their numbers. They all did bett...
+3
25
$Abbott Laboratories (ABT.US)$
The stock has break below the support 101.56. Looks bearish. Next support is 100.64.
The stock has break below the support 101.56. Looks bearish. Next support is 100.64.
1
$Abbott Laboratories (ABT.US)$
Bearish engulfing pattern appears in the chart. This stock has turned bearish. Next support is 101.56.
Bearish engulfing pattern appears in the chart. This stock has turned bearish. Next support is 101.56.
2
Morning Movers
Gapping up
$United Airlines (UAL.US)$ stock rose 5.2% after the carrier forecast stronger-than-expected earnings in the current quarter and reported a narrower-than-expected loss in the first quarter, buoyed by robust demand for travel.
$Abbott Laboratories (ABT.US)$ stock increased by 1.6% after the company surpassed quarterly profit expectations and raised the lower end of its earnings forecast, with strong dem...
Gapping up
$United Airlines (UAL.US)$ stock rose 5.2% after the carrier forecast stronger-than-expected earnings in the current quarter and reported a narrower-than-expected loss in the first quarter, buoyed by robust demand for travel.
$Abbott Laboratories (ABT.US)$ stock increased by 1.6% after the company surpassed quarterly profit expectations and raised the lower end of its earnings forecast, with strong dem...
31
$Abbott Laboratories (ABT.US)$
Introduction
On April 17th, before the US stock market opened, Abbott (NYSE: ABT) will hold a conference call to announce its financial results for the first quarter of 2024. As a global leader in healthcare, Abbott's performance has been steadily improving in recent years, especially benefiting from the COVID-19 pandemic. According to Bloomberg data, the follow...
Introduction
On April 17th, before the US stock market opened, Abbott (NYSE: ABT) will hold a conference call to announce its financial results for the first quarter of 2024. As a global leader in healthcare, Abbott's performance has been steadily improving in recent years, especially benefiting from the COVID-19 pandemic. According to Bloomberg data, the follow...
2
$Abbott Laboratories (ABT.US)$ Hmmm. As usual, red again
1
Insiders selling shares with no recorded purchases over the last year could worry investors. Despite high insider ownership, recent selling activity suggests insiders don't see shares as a bargain.
1
The 4- and 5-star rated Dividend Aristocrats for 2024 include Abbott Laboratories, AbbVie Inc., Air Products & Chemicals, and others such as Coca-Cola Co., McDonald's Corp., Walmart Inc., and West Pharmaceuticals.
2
No comment yet
103189865 : mony half widrow
103159190 : Why is McDonald's earnings forecast lower than expected and the pre-market price will rise?
104371487 On Paris : Thanks you
105535782 : ok
Captain Woon 103159190 : Market is irrational… buy on bad news
View more comments...